Coblation® intracapsular tonsillectomy in children with recurrent tonsillitis: Initial experience

Area of Science:

• Otolaryngology
• Pediatric Surgery

Background:

• Coblation® intracapsular tonsillectomy shows promise for sleep-disordered breathing (SDB)/obstructive sleep apnoea (OSA).
• Evidence for its efficacy in treating tonsillitis as the primary indication is less clear.
• This study evaluates initial results for pediatric tonsillectomy using Coblation® for infective indications.

Purpose of the Study:

• To assess the safety and effectiveness of Coblation® intracapsular tonsillectomy in pediatric patients with tonsillitis.
• To evaluate symptom improvement using the T14 tonsil symptom questionnaire.
• To document postoperative complications.

Main Methods:

• Prospective case series of 80 pediatric patients (ages 2-16) from January 2016 to July 2018.
• Utilized the validated T14 tonsil symptom questionnaire pre- and postoperatively.
• Collected data on postoperative complications, including hemorrhage and readmission.

Main Results:

• Significant reduction in overall T14 scores (32.7 to 2.7, p < 0.0001), infective scores (22.1 to 1.5, p < 0.0001), and SDB scores (10.6 to 1.5, p < 0.0001).
• Mean follow-up was 13 months.
• No cases of hemorrhage, re-admission, or tonsil regrowth were reported.

Conclusions:

• Coblation® intracapsular tonsillectomy is a safe and effective treatment for pediatric recurrent tonsillitis.
• The procedure demonstrates significant symptom improvement and a low complication rate.
• Further long-term follow-up studies are recommended.